Intravenous Esketamine Acts Faster, but Subcutaneous Route Matches Final Outcomes in Treatment-Resistant Depression
A multicenter Brazilian study finds intravenous esketamine produced faster antidepressant response in treatment-resistant depression, while a longer subcutaneous protocol achieved ...
